Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenica Lorusso

Showing results (21-30 of 374) with videos related to

Pageof 38
Sort By:
Gynecologic Oncology|February 4, 2014
A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancerDomenica Lorusso, Fausto Petrelli, Andrea Coinu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 15, 2019
Capecitabine in patients with platinum-pretreated advanced or recurrent cervical carcinoma: a retrospective studyGiuseppa Maltese, Stefano Lepori, Ilaria Sabatucci, et al.
Sarcoma|June 20, 2015
Management Strategies in Advanced Uterine Leiomyosarcoma: Focus on TrabectedinFrédéric Amant, Domenica Lorusso, Alexander Mustea, et al.
Gynecologic Oncology|February 7, 2013
Advanced ovarian cancer: omental bursa, lesser omentum, celiac, portal and triad nodes spread as cause of inaccurate evaluation of residual tumorFrancesco Raspagliesi, Antonino Ditto, Fabio Martinelli, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 8, 2022
Management of stage III and IVa uterine cancerCamilla Nero, Francesca Tronconi, Elena Giudice, et al.
Cancers|September 10, 2021
Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future PerspectivesBrigida Anna Maiorano, Mauro Francesco Pio Maiorano, Domenica Lorusso, et al.
Gynecologic Oncology|May 6, 2014
Radiotherapy with concurrent cisplatin-based doublet or weekly cisplatin for cervical cancer: a systematic review and meta-analysisFausto Petrelli, Agostina De Stefani, Francesco Raspagliesi, et al.
Expert Opinion on Investigational Drugs|February 17, 2007
Investigational agents against platinum-resistant ovarian cancerDomenica Lorusso, Gabriella Ferrandina, Francesco Fanfani, et al.
The Oncologist|September 20, 2022
An Indirect Comparison of the Efficacy and Safety of Dostarlimab and Doxorubicin for the Treatment of Advanced and Recurrent Endometrial CancerCara Mathews, Domenica Lorusso, Robert L Coleman, et al.
Expert Opinion on Pharmacotherapy|April 20, 2018
Rucaparib: a new treatment option for ovarian cancerIlaria Sabatucci, Giuseppa Maltese, Stefano Lepori, et al.
Pageof 38

Showing results (21-30 of 374) with videos related to

Sort By:
Pageof 38
Gynecologic Oncology|February 4, 2014
A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancerDomenica Lorusso, Fausto Petrelli, Andrea Coinu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 15, 2019
Capecitabine in patients with platinum-pretreated advanced or recurrent cervical carcinoma: a retrospective studyGiuseppa Maltese, Stefano Lepori, Ilaria Sabatucci, et al.
Sarcoma|June 20, 2015
Management Strategies in Advanced Uterine Leiomyosarcoma: Focus on TrabectedinFrédéric Amant, Domenica Lorusso, Alexander Mustea, et al.
Gynecologic Oncology|February 7, 2013
Advanced ovarian cancer: omental bursa, lesser omentum, celiac, portal and triad nodes spread as cause of inaccurate evaluation of residual tumorFrancesco Raspagliesi, Antonino Ditto, Fabio Martinelli, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 8, 2022
Management of stage III and IVa uterine cancerCamilla Nero, Francesca Tronconi, Elena Giudice, et al.
Cancers|September 10, 2021
Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future PerspectivesBrigida Anna Maiorano, Mauro Francesco Pio Maiorano, Domenica Lorusso, et al.
Gynecologic Oncology|May 6, 2014
Radiotherapy with concurrent cisplatin-based doublet or weekly cisplatin for cervical cancer: a systematic review and meta-analysisFausto Petrelli, Agostina De Stefani, Francesco Raspagliesi, et al.
Expert Opinion on Investigational Drugs|February 17, 2007
Investigational agents against platinum-resistant ovarian cancerDomenica Lorusso, Gabriella Ferrandina, Francesco Fanfani, et al.
The Oncologist|September 20, 2022
An Indirect Comparison of the Efficacy and Safety of Dostarlimab and Doxorubicin for the Treatment of Advanced and Recurrent Endometrial CancerCara Mathews, Domenica Lorusso, Robert L Coleman, et al.
Expert Opinion on Pharmacotherapy|April 20, 2018
Rucaparib: a new treatment option for ovarian cancerIlaria Sabatucci, Giuseppa Maltese, Stefano Lepori, et al.
Pageof 38